Use of Placental Growth Factor for Trisomy 21 Screening in Pregnancy: A Systematic Review

Background  Prenatal serum screening is an important modality to screen for aneuploidy in pregnancy. The addition of placental growth factor (PLGF) to screen for trisomy 21 remains controversial. Objective  To determine whether the addition of PLGF to combined serum aneuploidy screening improves det...

Descripción completa

Detalles Bibliográficos
Autores principales: Badeghiesh, Ahmad, Volodarsky-Perel, Alexander, Lasry, Ariane, Hemmings, Robert, Gil, Yaron, Balayla, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571571/
https://www.ncbi.nlm.nih.gov/pubmed/33094011
http://dx.doi.org/10.1055/s-0040-1713785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571571/
https://www.ncbi.nlm.nih.gov/pubmed/33094011
http://dx.doi.org/10.1055/s-0040-1713785

Ejemplares similares